BioProtect brings to market implantable, biodegradable balloon systems based on
its proprietary technology. The balloons may be used for various clinical applications in the fields of oncology, general surgery.
The company’s first product, the BioProtect Balloon Implant, protects the rectum from the potential risk of rectal toxicity in patients undergoing radiation therapy for prostate cancer. With the balloon implant, safe high-dose radiation therapy (including dose escalation and hypofractionation) is made possible, dramatically decreasing the probability of patient G2 acute rectal toxicity while improving biochemical tumor control.